The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global SARS-CoV-2 IgG (RBD) ELISA Market Research Report 2025
Synopsis
The global SARS-CoV-2 IgG (RBD) ELISA market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for SARS-CoV-2 IgG (RBD) ELISA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for SARS-CoV-2 IgG (RBD) ELISA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for SARS-CoV-2 IgG (RBD) ELISA in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of SARS-CoV-2 IgG (RBD) ELISA include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences and BioMérieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for SARS-CoV-2 IgG (RBD) ELISA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SARS-CoV-2 IgG (RBD) ELISA.
Report Scope
The SARS-CoV-2 IgG (RBD) ELISA market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global SARS-CoV-2 IgG (RBD) ELISA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the SARS-CoV-2 IgG (RBD) ELISA companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
LOEWE Biochemica
Shenzhen YHLO Biotech
LG
Segment by Type
ELISA Sets
ELISA Kits
Segment by Application
Hospital
Clinic
Disease control and prevention system
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of SARS-CoV-2 IgG (RBD) ELISA companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global SARS-CoV-2 IgG (RBD) ELISA market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for SARS-CoV-2 IgG (RBD) ELISA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for SARS-CoV-2 IgG (RBD) ELISA is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for SARS-CoV-2 IgG (RBD) ELISA in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of SARS-CoV-2 IgG (RBD) ELISA include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences and BioMérieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for SARS-CoV-2 IgG (RBD) ELISA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SARS-CoV-2 IgG (RBD) ELISA.
Report Scope
The SARS-CoV-2 IgG (RBD) ELISA market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global SARS-CoV-2 IgG (RBD) ELISA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the SARS-CoV-2 IgG (RBD) ELISA companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
LOEWE Biochemica
Shenzhen YHLO Biotech
LG
Segment by Type
ELISA Sets
ELISA Kits
Segment by Application
Hospital
Clinic
Disease control and prevention system
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of SARS-CoV-2 IgG (RBD) ELISA companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ELISA Sets
1.2.3 ELISA Kits
1.3 Market by Application
1.3.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Disease control and prevention system
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Perspective (2019-2030)
2.2 SARS-CoV-2 IgG (RBD) ELISA Growth Trends by Region
2.2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 SARS-CoV-2 IgG (RBD) ELISA Historic Market Size by Region (2019-2024)
2.2.3 SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Region (2025-2030)
2.3 SARS-CoV-2 IgG (RBD) ELISA Market Dynamics
2.3.1 SARS-CoV-2 IgG (RBD) ELISA Industry Trends
2.3.2 SARS-CoV-2 IgG (RBD) ELISA Market Drivers
2.3.3 SARS-CoV-2 IgG (RBD) ELISA Market Challenges
2.3.4 SARS-CoV-2 IgG (RBD) ELISA Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Revenue
3.1.1 Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Revenue (2019-2024)
3.1.2 Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Players (2019-2024)
3.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by SARS-CoV-2 IgG (RBD) ELISA Revenue
3.4 Global SARS-CoV-2 IgG (RBD) ELISA Market Concentration Ratio
3.4.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by SARS-CoV-2 IgG (RBD) ELISA Revenue in 2023
3.5 SARS-CoV-2 IgG (RBD) ELISA Key Players Head office and Area Served
3.6 Key Players SARS-CoV-2 IgG (RBD) ELISA Product Solution and Service
3.7 Date of Enter into SARS-CoV-2 IgG (RBD) ELISA Market
3.8 Mergers & Acquisitions, Expansion Plans
4 SARS-CoV-2 IgG (RBD) ELISA Breakdown Data by Type
4.1 Global SARS-CoV-2 IgG (RBD) ELISA Historic Market Size by Type (2019-2024)
4.2 Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Type (2025-2030)
5 SARS-CoV-2 IgG (RBD) ELISA Breakdown Data by Application
5.1 Global SARS-CoV-2 IgG (RBD) ELISA Historic Market Size by Application (2019-2024)
5.2 Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size (2019-2030)
6.2 North America SARS-CoV-2 IgG (RBD) ELISA Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2019-2024)
6.4 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size (2019-2030)
7.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2019-2024)
7.4 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size (2019-2030)
8.2 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2019-2024)
8.4 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size (2019-2030)
9.2 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2019-2024)
9.4 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size (2019-2030)
10.2 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2019-2024)
10.4 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 R&D Systems
11.1.1 R&D Systems Company Detail
11.1.2 R&D Systems Business Overview
11.1.3 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Introduction
11.1.4 R&D Systems Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.1.5 R&D Systems Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Introduction
11.2.4 Thermo Fisher Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Ortho Clinical Diagnostics
11.3.1 Ortho Clinical Diagnostics Company Detail
11.3.2 Ortho Clinical Diagnostics Business Overview
11.3.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Introduction
11.3.4 Ortho Clinical Diagnostics Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.3.5 Ortho Clinical Diagnostics Recent Development
11.4 BD Biosciences
11.4.1 BD Biosciences Company Detail
11.4.2 BD Biosciences Business Overview
11.4.3 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Introduction
11.4.4 BD Biosciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.4.5 BD Biosciences Recent Development
11.5 ZEUS Scientific
11.5.1 ZEUS Scientific Company Detail
11.5.2 ZEUS Scientific Business Overview
11.5.3 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Introduction
11.5.4 ZEUS Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.5.5 ZEUS Scientific Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Introduction
11.6.4 Bio-Rad Laboratories Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 ALPCO
11.7.1 ALPCO Company Detail
11.7.2 ALPCO Business Overview
11.7.3 ALPCO SARS-CoV-2 IgG (RBD) ELISA Introduction
11.7.4 ALPCO Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.7.5 ALPCO Recent Development
11.8 Enzo Life Sciences
11.8.1 Enzo Life Sciences Company Detail
11.8.2 Enzo Life Sciences Business Overview
11.8.3 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Introduction
11.8.4 Enzo Life Sciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.8.5 Enzo Life Sciences Recent Development
11.9 BioMérieux
11.9.1 BioMérieux Company Detail
11.9.2 BioMérieux Business Overview
11.9.3 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Introduction
11.9.4 BioMérieux Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.9.5 BioMérieux Recent Development
11.10 LOEWE Biochemica
11.10.1 LOEWE Biochemica Company Detail
11.10.2 LOEWE Biochemica Business Overview
11.10.3 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Introduction
11.10.4 LOEWE Biochemica Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.10.5 LOEWE Biochemica Recent Development
11.11 Shenzhen YHLO Biotech
11.11.1 Shenzhen YHLO Biotech Company Detail
11.11.2 Shenzhen YHLO Biotech Business Overview
11.11.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Introduction
11.11.4 Shenzhen YHLO Biotech Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.11.5 Shenzhen YHLO Biotech Recent Development
11.12 LG
11.12.1 LG Company Detail
11.12.2 LG Business Overview
11.12.3 LG SARS-CoV-2 IgG (RBD) ELISA Introduction
11.12.4 LG Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
11.12.5 LG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of ELISA Sets
Table 3. Key Players of ELISA Kits
Table 4. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2019-2024)
Table 8. Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2025-2030)
Table 10. SARS-CoV-2 IgG (RBD) ELISA Market Trends
Table 11. SARS-CoV-2 IgG (RBD) ELISA Market Drivers
Table 12. SARS-CoV-2 IgG (RBD) ELISA Market Challenges
Table 13. SARS-CoV-2 IgG (RBD) ELISA Market Restraints
Table 14. Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Players (2019-2024)
Table 16. Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SARS-CoV-2 IgG (RBD) ELISA as of 2023)
Table 17. Ranking of Global Top SARS-CoV-2 IgG (RBD) ELISA Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by SARS-CoV-2 IgG (RBD) ELISA Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players SARS-CoV-2 IgG (RBD) ELISA Product Solution and Service
Table 21. Date of Enter into SARS-CoV-2 IgG (RBD) ELISA Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2019-2024)
Table 25. Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2025-2030)
Table 27. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2019-2024)
Table 29. Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2025-2030)
Table 31. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2025-2030) & (US$ Million)
Table 46. R&D Systems Company Detail
Table 47. R&D Systems Business Overview
Table 48. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product
Table 49. R&D Systems Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 50. R&D Systems Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product
Table 54. Thermo Fisher Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Ortho Clinical Diagnostics Company Detail
Table 57. Ortho Clinical Diagnostics Business Overview
Table 58. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product
Table 59. Ortho Clinical Diagnostics Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 60. Ortho Clinical Diagnostics Recent Development
Table 61. BD Biosciences Company Detail
Table 62. BD Biosciences Business Overview
Table 63. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product
Table 64. BD Biosciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 65. BD Biosciences Recent Development
Table 66. ZEUS Scientific Company Detail
Table 67. ZEUS Scientific Business Overview
Table 68. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product
Table 69. ZEUS Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 70. ZEUS Scientific Recent Development
Table 71. Bio-Rad Laboratories Company Detail
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product
Table 74. Bio-Rad Laboratories Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. ALPCO Company Detail
Table 77. ALPCO Business Overview
Table 78. ALPCO SARS-CoV-2 IgG (RBD) ELISA Product
Table 79. ALPCO Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 80. ALPCO Recent Development
Table 81. Enzo Life Sciences Company Detail
Table 82. Enzo Life Sciences Business Overview
Table 83. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product
Table 84. Enzo Life Sciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 85. Enzo Life Sciences Recent Development
Table 86. BioMérieux Company Detail
Table 87. BioMérieux Business Overview
Table 88. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product
Table 89. BioMérieux Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 90. BioMérieux Recent Development
Table 91. LOEWE Biochemica Company Detail
Table 92. LOEWE Biochemica Business Overview
Table 93. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product
Table 94. LOEWE Biochemica Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 95. LOEWE Biochemica Recent Development
Table 96. Shenzhen YHLO Biotech Company Detail
Table 97. Shenzhen YHLO Biotech Business Overview
Table 98. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product
Table 99. Shenzhen YHLO Biotech Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 100. Shenzhen YHLO Biotech Recent Development
Table 101. LG Company Detail
Table 102. LG Business Overview
Table 103. LG SARS-CoV-2 IgG (RBD) ELISA Product
Table 104. LG Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024) & (US$ Million)
Table 105. LG Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Type: 2023 VS 2030
Figure 3. ELISA Sets Features
Figure 4. ELISA Kits Features
Figure 5. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Disease control and prevention system Case Studies
Figure 10. SARS-CoV-2 IgG (RBD) ELISA Report Years Considered
Figure 11. Global SARS-CoV-2 IgG (RBD) ELISA Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global SARS-CoV-2 IgG (RBD) ELISA Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region: 2023 VS 2030
Figure 14. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Players in 2023
Figure 15. Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SARS-CoV-2 IgG (RBD) ELISA as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by SARS-CoV-2 IgG (RBD) ELISA Revenue in 2023
Figure 17. North America SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2019-2030)
Figure 19. United States SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2019-2030)
Figure 23. Germany SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2019-2030)
Figure 31. China SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2019-2030)
Figure 39. Mexico SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2019-2030)
Figure 43. Turkey SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. R&D Systems Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 47. Ortho Clinical Diagnostics Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 48. BD Biosciences Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 49. ZEUS Scientific Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 50. Bio-Rad Laboratories Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 51. ALPCO Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 52. Enzo Life Sciences Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 53. BioMérieux Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 54. LOEWE Biochemica Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 55. Shenzhen YHLO Biotech Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 56. LG Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
